[gtranslate]

新闻

1766118963787

Dual-Target ADC Achieves “1+1>2” Synergistic Killing: Four Core Dimensions Are Key

The “1+1>2” effect of ...

1765778766257

ASGR1 Overexpression Cell Lines Drive IgA Nephropathy and Breakthroughs in Multidisciplinary Drug R&D

IgA nephropathy (IgAN), t...

1763999113764

World’s 1st Bio-Thera’s EGFR/HER3 Bispecific ADC Succeeds in Phase III: Kyinno’s Common Light Chain Mouse Platform Supports Bispecific ADC Development

On July 2, 2025, Bio-Ther...

1765170688218

Rapid Tracking, Precise Degradation: ESR1-HiBiT-KI Cell Line Breaks Through the Challenge of Breast Cancer Drug Resistance

Recently, there has been ...

1763352794711

CD8, From Immune Sentinel to Anticancer Target: Unpacking the Therapeutic Revolution of the Core T Cell Receptor

The CD8 molecule is not o...

1762840333092 (1)

WRN MutCell Platform, Advancing Precision Resistance Research · Driving New Drug Breakthroughs

At the AACR symposium “Ex...

1762840333092

WRN MutCell Platform, Advancing Precision Resistance Research · Driving New Drug Breakthroughs

At the AACR symposium “Ex...

1760928127935

Who Will Lead the Race in Targeted Radiopharmaceuticals?

On June 10, RayzeBio, a w...

ScreenShot_2025-10-20_115431_102

Kyinno Biotechnology at AACR-EORTC 2025

Kyinno Biotechnology, Inc...

1760335895427

Establishing a Precision Tumor Model: Launch of the A375-NRAS-Q61K-KI Cell Line

A phase II clinical study...